Last updated: 11/08/2018 17:18:04

Study to evaluate the effect of fluticasone furoate/vilanterol on survival in subjects with chronic obstructive pulmonary disease

GSK study ID
113782
Clinicaltrials.gov ID
EudraCT ID
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease
Trial description: The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a history of or increased risk of heart disease.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:

Number of participants with death (both on and off treatment) due to any cause, time up to or on the pre-determined common end date

Timeframe: From the date of randomization until date of death due to any cause (average of 2 study years)

Secondary outcomes:

Decline in forced expiratory volume in 1 second (FEV1)

Timeframe: From start date of IP until IP stop date + 1 (assessed up to 4 years)

Number of participants with first on-treatment cardiovascular (CV) composite events occured on or before common end date

Timeframe: From the start of IP to first on treatment CV event till 7 days after the last dose of IP (average of 2 study years)

Interventions:
  • Drug: fluticasone furoate/vilanterol
  • Drug: fluticasone furoate
  • Drug: vilanterol
  • Other: Placebo
  • Enrollment:
    16568
    Primary completion date:
    2015-15-07
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Jørgen Vestbo, Julie A Anderson, Robert D Brook, Peter MA Calverley, Bartolome R Celli, Courtney Crim, Fernando Martinez, Julie Yates, David E Newby. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk. Lancet. 2016;387(10030):1789-1878
    Medical condition
    Pulmonary Disease, Chronic Obstructive
    Product
    fluticasone furoate, fluticasone furoate/vilanterol, vilanterol
    Collaborators
    Not applicable
    Study date(s)
    January 2011 to July 2015
    Type
    Interventional
    Phase
    3

    Participation criteria

    Sex
    Female & Male
    Age
    40 - 80 years
    Accepts healthy volunteers
    No
    • Type of subject: outpatient.
    • Informed consent: Subjects must give their signed and dated written informed consent to participate.
    • Pregnancy: Women who are pregnant or lactating.
    • Asthma: Subjects with a current diagnosis of asthma. (Subjects with a prior history of asthma are eligible if they also have a current diagnosis of COPD).

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Elizabeth, New Jersey, United States, 07201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15213
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Anaheim, California, United States, 92801
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Decatur, Georgia, United States, 30033
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Skopje, Macedonia, 1000
    Status
    Study Complete
    Location
    GSK Investigational Site
    North Dartmouth, Massachusetts, United States, 02747
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 12099
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nagykanizsa, Hungary, 8800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cape Town, South Africa, 7700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pitesti, Romania, 110084
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gwangju, South Korea, 501-757
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rosario, Santa Fe, Argentina, S2000CVD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Medan, Indonesia, 20111
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Rock Hill, South Carolina, United States, 29732
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sarasota, Florida, United States, 34239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bronxville, New York, United States, 10708
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santa Fe, Santa Fe, Argentina, 3016
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shelby, North Carolina, United States, 28152
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ivano-Frankivsk, Ukraine, 76018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elblag, Poland, 82-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pasay, Philippines, 1300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Reinfeld, Schleswig-Holstein, Germany, 23858
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 92-107
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10787
    Status
    Study Complete
    Location
    GSK Investigational Site
    Budapest, Hungary, 1117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bonn, Nordrhein-Westfalen, Germany, 53119
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bucuresti, Romania, 030303
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hokkaido, Japan, 070-8644
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Jose, California, United States, 95116
    Status
    Study Complete
    Location
    GSK Investigational Site
    Uniontown, Pennsylvania, United States, 15401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wodzislaw Slaski, Poland, 44-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aichi, Japan, 454-8502
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bialystok, Poland, 15-003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Skierniewice, Poland, 96-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dnipropetrovsk, Ukraine, 49005
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pontianak, Indonesia, 78122
    Status
    Study Complete
    Location
    GSK Investigational Site
    Strmec Samoborski, Croatia, 10434
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10019
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Great Falls, Montana, United States, 59405
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Phitsanulok, Thailand, 65000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wroclaw, Poland, 54-239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1028AAP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Calhoun, Georgia, United States, 30701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Komarom, Hungary, 2900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Katowice, Poland, 40-954
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chiangrai, Thailand, 57000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Nyiregyhaza, Hungary, 4400
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Cluj-Napoca, Romania, 400352
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kharkiv, Ukraine, 61039
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lufkin, Texas, United States, 75904
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lincoln, Nebraska, United States, 02865
    Status
    Study Complete
    Location
    GSK Investigational Site
    Semarang, Indonesia, 50242
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kiev, Ukraine, 03680
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torrance/California, California, United States, 90505
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ogre, Latvia, LV - 5001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lewisville, Texas, United States, 75067
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minsk, Belarus, 223041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oviedo, Spain, 33006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ankara, Turkey, 06590
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pinellas Park, Florida, United States, 33781
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77030
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lynnwood Ridge, South Africa, 0014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brighton, United Kingdom, BN2 5BE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nagpur, India, 440019
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ferolles Attilly, France, 77150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gyula, Hungary, 5703
    Status
    Study Complete
    Location
    GSK Investigational Site
    McKinney, Texas, United States, 75069
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ozark, Alabama, United States, 36360
    Status
    Study Complete
    Location
    GSK Investigational Site
    Budapest, Hungary, 1125
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Pune, India, 411014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75225
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palma de Mallorca, Spain, 07010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Coronel Suarez, Argentina, 7540
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pasadena, California, United States, 91105
    Status
    Study Complete
    Location
    GSK Investigational Site
    Banda Aceh, Indonesia, 23126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mons, Belgium, 7000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kherson, Ukraine, 73000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R3H 2A6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45242
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kazan, Russia, 420012
    Status
    Study Complete
    Location
    GSK Investigational Site
    St.Petersburg, Russia, 191025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chelyabinsk, Russia, 454091
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Banos, Philippines, 4030
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bogota, Colombia
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elkton, Maryland, United States, 21921
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poznan, Poland, 60-773
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33165
    Status
    Study Complete
    Location
    GSK Investigational Site
    Metairie, Louisiana, United States, 70006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tarnow, Poland, 33-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, United Kingdom, EC1M 6BQ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fukuoka, Japan, 832-0059
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boksburg, Gauteng, South Africa, 1459
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trivandrum, India, 695004
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mendoza, Mendoza, Argentina, MM5500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Constanta, Romania, 900002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seoul, South Korea
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chelyabinsk, Russia, 454021
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10038
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Arkhangelsk, Russia, 163001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Odesa, Ukraine, 65010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thessaloniki, Greece, 57010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Evergreen Park, Illinois, United States, 60805
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bialystok, Poland, 15-044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 115432
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pensacola, Florida, United States, 32503
    Status
    Study Complete
    Location
    GSK Investigational Site
    CapeTown, South Africa, 7764
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84102
    Status
    Study Complete
    Location
    GSK Investigational Site
    Namur, Belgium, 5000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bay Pines, Florida, United States, 33744
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pamplona, Spain, 31008
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ho Chi Minh, Vietnam, 70000
    Status
    Study Complete
    Location
    GSK Investigational Site
    South Miami, Florida, United States, 33143
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olawa, Poland, 55-200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plock, Poland, 09-402
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shimane, Japan, 690-8509
    Status
    Study Complete
    Location
    GSK Investigational Site
    Presov, Slovakia, 081 81
    Status
    Study Complete
    Location
    GSK Investigational Site
    Peoria, Illinois, United States, 61602
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cape Town, South Africa, 7500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ekaterinburg, Russia, 620137
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Worth, Texas, United States, 76104
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Coeur d'Alene, Idaho, United States, 90212
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Goyang-si, South Korea, 411706
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chihuahua, Chihuahua, Mexico, 31238
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ha Noi, Vietnam, 10000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucuman, Tucumán, Argentina, 4000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Fleetwood, Pennsylvania, United States, 19522
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 198103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Xian, Shaanxi, China, 710032
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salem, New Jersey, United States, 08079
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 196084
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chongqing, China, 400042
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saratov, Russia, 410028
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kyiv, Ukraine, 03038
    Status
    Study Complete
    Location
    GSK Investigational Site
    Foca, Bosnia and Herzegovina, 73300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L4T 4J2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbus, Ohio, United States, 43213
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olathe, Kansas, United States, 66061
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33765-2616
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 119620
    Status
    Study Complete
    Location
    GSK Investigational Site
    Strumica, Macedonia, 2400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stubicke toplice, Croatia, 49244
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sofia, Bulgaria, 1505
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cordoba, Córdova, Argentina, X5003DCE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bucharest, Romania, 020125
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bellevue, Nebraska, United States, 68123-4303
    Status
    Study Complete
    Location
    GSK Investigational Site
    Somerset West, South Africa, 7130
    Status
    Study Complete
    Location
    GSK Investigational Site
    Neuss, Nordrhein-Westfalen, Germany, 41462
    Status
    Study Complete
    Location
    GSK Investigational Site
    Iasi, Romania, 700656
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Meyerspark, Gauteng, South Africa, 0184
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wroclaw, Poland, 50-088
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jakarta, Indonesia, 12430
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Simi Valley, California, United States, 93065
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rochester, New York, United States, 14618
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brockton, Massachusetts, United States, 02301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aurangabad, India, 431001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 119991
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orenburg, Russia, 460018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pelzer, South Carolina, United States, 29669
    Status
    Study Complete
    Location
    GSK Investigational Site
    Abingdon, Virginia, United States, 24210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bydgoszcz, Poland, 85-863
    Status
    Study Complete
    Location
    GSK Investigational Site
    Biddeford, Maine, United States, 04005
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plzen, Czech Republic, 301 00
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntsville, Alabama, United States, 35801
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palembang, Indonesia, 30126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pila, Poland, 64-920
    Status
    Study Complete
    Location
    GSK Investigational Site
    Feldkirchen, Bayern, Germany, 83620
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tbilisi, Georgia, 0159
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wheatridge, Colorado, United States, 80033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Loma Linda, California, United States, 92357
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leipzig, Sachsen, Germany, 04357
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chengdu, China, 610041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 195112
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cipoletti, Rio Negro, Río Negro, Argentina, R8324CVE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zipaquira, Colombia
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taichung, Taiwan, 40201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kuldiga, Latvia, LV - 3301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montgomery/Alabama, Alabama, United States, 36106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Champaign, Illinois, United States, 61820
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 198260
    Status
    Study Complete
    Location
    GSK Investigational Site
    Akron, Ohio, United States, 44313
    Status
    Study Complete
    Location
    GSK Investigational Site
    Roodepoort, South Africa, 1724
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wels, Austria, 4600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5J 3S9
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tatabanya, Hungary, 2800
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Isidro, Buenos Aires, Argentina, B1642DCD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gifu, Japan, 500-8717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morgantown, West Virginia, United States, 26505
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poznan, Poland, 60-569
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbia, Maryland, United States, 21044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zgierz, Poland, 95-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 117630
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corsicana, Texas, United States, 75110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cebu City, Philippines, 6000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haikou, Hainan, China, 570001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ivankovo, Croatia, 32281
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77043
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corpus Christi, Texas, United States, 78405
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Surabaya, Indonesia, 60286
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quincy, Illinois, United States, 62301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riga, Latvia, LV-1010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ostrava, Czech Republic, 72880
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gabrovo, Bulgaria, 5300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenwood, South Carolina, United States, 29646
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, Gauteng, South Africa, 0181
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taiping Perak, Malaysia, 34000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kettering, Ohio, United States, 45429
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zagreb, Croatia, 10000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lehigh Acres, Florida, United States, 33971
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sofia, Bulgaria, 1431
    Status
    Study Complete
    Location
    GSK Investigational Site
    Skarzysko-Kamienna, Poland, 26-110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oak Lawn, Illinois, United States, 60453
    Status
    Study Complete
    Location
    GSK Investigational Site
    Szigetszentmiklos, Hungary, 2310
    Status
    Study Complete
    Location
    GSK Investigational Site
    Modesto, California, United States, 95350
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Cacak, Serbia, 32000
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greer, South Carolina, United States, 29650
    Status
    Study Complete
    Location
    GSK Investigational Site
    Galveston, Texas, United States, 77555
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warszawa, Poland, 01-138
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Florida, United States, 33713
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lincoln, Nebraska, United States, 68506
    Status
    Study Complete
    Location
    GSK Investigational Site
    Troy, Michigan, United States, 48085
    Status
    Study Complete
    Location
    GSK Investigational Site
    Adrogue, Buenos Aires, Argentina, B1846DSK
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plzen, Czech Republic, 323 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jaromer, Czech Republic, 551 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32209
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sacramento, California, United States, 95821
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23229
    Status
    Study Complete
    Location
    GSK Investigational Site
    ShangHai, China, 200062
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35209
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valencia, Spain, 46017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benidorm, Spain, 03501
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bergisch Gladbach, Nordrhein-Westfalen, Germany, 51429
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kissimmee, Florida, United States, 34741
    Status
    Study Complete
    Location
    GSK Investigational Site
    Monterrey, Mexico, 64060
    Status
    Study Complete
    Location
    GSK Investigational Site
    Samobor, Croatia, 10430
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dresden, Sachsen, Germany, 01067
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Taipei, Taiwan, 235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Szczecin, Poland, 71-124
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78229
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78212
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pune, India, 411015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tver, Russia, 170036
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winston-Salem, North Carolina, United States, 27103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marburg, Hessen, Germany, 35037
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fremont, Nebraska, United States, 68025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salta, Salta, Argentina, A4400ANG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tampa, Florida, United States, 33613
    Status
    Study Complete
    Location
    GSK Investigational Site
    Topeka, Kansas, United States, 66615
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bitola, Macedonia, 7000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 105066
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shimane, Japan, 690-8556
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ulsan, South Korea, 682-714
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nueve de Julio, Buenos Aires, Argentina, B6500BWQ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vinnytsia, Ukraine, 21018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poltava, Ukraine, 36024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rincon, Georgia, United States, 31326
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alabang, Muntinlupa City, Philippines, 1780
    Status
    Study Complete
    Location
    GSK Investigational Site
    München, Germany, 81677
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Moscow, Russia, 119002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 196601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 117593
    Status
    Study Complete
    Location
    GSK Investigational Site
    Towson, Maryland, United States, 21204
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Maumee, Ohio, United States, 43537-9402
    Status
    Study Complete
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97219
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riga, Latvia, LV 1002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Franklin, Indiana, United States, 46131
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 129090
    Status
    Study Complete
    Location
    GSK Investigational Site
    Incheon, South Korea, 403-720
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dubuque, Iowa, United States, 52001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, South Africa, 0002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cavite, Philippines, 4114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Medellin, Colombia
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 4, Czech Republic, 140 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Belgrade, Serbia, 11000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Middelburg, Mpumalanga, South Africa, 1055
    Status
    Study Complete
    Location
    GSK Investigational Site
    Austin, Texas, United States, 78758
    Status
    Study Complete
    Location
    GSK Investigational Site
    Targu-Mures, Romania, 540142
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 5, Czech Republic, 150 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Midvale, Utah, United States, 84047
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charlotte, North Carolina, United States, 28209
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saratov, Russia, 410054
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 119121
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cottbus, Brandenburg, Germany, 03050
    Status
    Study Complete
    Location
    GSK Investigational Site
    Daugavpils, Latvia, LV5410
    Status
    Study Complete
    Location
    GSK Investigational Site
    Niles, Michigan, United States, 49120
    Status
    Study Complete
    Location
    GSK Investigational Site
    McKinney, Texas, United States, 75071
    Status
    Study Complete
    Location
    GSK Investigational Site
    Holon, Israel, 68125
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ostrow Wilekopolski, Poland, 63-400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Iloilo City, Philippines, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 197022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lanús, Argentina, B1824KAJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntsville, Alabama, United States, 35816
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sibenik, Croatia, 22000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Riesa, Sachsen, Germany, 01587
    Status
    Study Complete
    Location
    GSK Investigational Site
    Monterrey, Nuevo León, Mexico, 64710
    Status
    Study Complete
    Location
    GSK Investigational Site
    Padang, Indonesia, 25127
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zalaegerszeg, Hungary, 8900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chengdu, Sichuan, China, 610083
    Status
    Study Complete
    Location
    GSK Investigational Site
    Milton Keynes, United Kingdom, MK6 5LD
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Suwanee, Georgia, United States, 30024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Merida, Mexico, 97000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75216
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gracanica, Bosnia and Herzegovina, 75320
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nove Zamky, Slovakia, 940 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sugarland, Texas, United States, 77478
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, Gauteng, South Africa, 0041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Amarillo, Texas, United States, 79124
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barcelona, Spain, 08041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Caloocan, Philippines, 1400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riverside, California, United States, 92506
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shenzhen, Guangdong, China, 518020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Margate, New Jersey, United States, 08402
    Status
    Study Complete
    Location
    GSK Investigational Site
    St'Petersburg, Russia, 193312
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cape Town, South Africa, 8001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Manila, Philippines, 1000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montgomery, Alabama, United States, 36109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wichita, Kansas, United States, 67218
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chesterfield, Missouri, United States, 63017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boerne, Texas, United States, 78006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tomsk, Russia, 634 050
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gdansk, Poland, 80-286
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nampa, Idaho, United States, 83687
    Status
    Study Complete
    Location
    GSK Investigational Site
    Monterey Park, California, United States, 91754
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bucheon, South Korea, 420-717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Liberec, Czech Republic, 460 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dayton, Ohio, United States, 45406
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sidcup, Kent, United Kingdom, DA14 6LT
    Status
    Study Complete
    Location
    GSK Investigational Site
    Codlea, Romania, 505100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10330
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hialeah, Florida, United States, 33016
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Quezon City, Philippines, 1109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chennai, India, 600100
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kagawa, Japan, 762-0031
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wuxi, China, 214023
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Billings, Montana, United States, 59101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Celebration, Florida, United States, 34747
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quezon City, Philippines, 1102
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33155
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lakewood, California, United States, 90712
    Status
    Study Complete
    Location
    GSK Investigational Site
    Council Bluffs, Iowa, United States, 51503
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rokycany, Czech Republic, 337 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Varna, Bulgaria, 9000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gilly, Belgium, 6060
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sarajevo, Bosnia and Herzegovina, 71000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Buenos Aires, Buenos Aires, Argentina, C1425AGC
    Status
    Study Complete
    Location
    GSK Investigational Site
    Angamaly, India, 683 572
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vienna, Austria, A-1120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sliven, Bulgaria, 8800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rosario, Santa Fe, Argentina, 2000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Athens, Greece, 15126
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kemerovo, Russia, 650002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbus,, Ohio, United States, 43214
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Calabash, North Carolina, United States, 28467
    Status
    Study Complete
    Location
    GSK Investigational Site
    Midlothian, Virginia, United States, 23114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Waterbury, Connecticut, United States, 06708
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangor, Maine, United States, 04401
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Fort Lauderdale, Florida, United States, 33316
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ohrid, Macedonia, 6000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Travnik, Bosnia and Herzegovina, 72270
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Collins, Colorado, United States, 80538
    Status
    Study Complete
    Location
    GSK Investigational Site
    Veliko Tarnovo, Bulgaria, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quilmes, Buenos Aires, Argentina, 1878
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ostrowiec Swietokrzyski, Poland, 27-400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Suwon, Gyeonggi-do, South Korea, 442-723
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    St. Petersburg, Russia, 194356
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arad, Romania, 310013
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santiago del Estero, Santiago Del Estero, Argentina
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Collins, Colorado, United States, 80528
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yaroslavl, Russia, 150002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oakland Park, Florida, United States, 33309
    Status
    Study Complete
    Location
    GSK Investigational Site
    Razgrad, Bulgaria, 7200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mysore, India, 570004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kraslava, Latvia, LV - 5601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warszawa, Poland, 01-868
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19152
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15243
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 194044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Encinitas, California, United States, 92024
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Monte Grande, Argentina, 1842
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vasarosnameny, Hungary, 4800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nizhniy Novgorod, Russia, 603035
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45220
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zephyrhills, Florida, United States, 33540
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benesov, Czech Republic, 256 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aichi, Japan, 457-8511
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tuzla, Bosnia and Herzegovina, 75000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44106
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Cape Town, South Africa, 7441
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Zhanjiang, Guangdong, China, 524001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cordoba, Argentina, X5006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nanning, Guangxi, China, 530021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Karlovac, Croatia, 47000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ann Arbor, Michigan, United States, 48106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jelgava, Latvia, LV - 3001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Scotdale, Pennsylvania, United States, 15683
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zhytomyr, Ukraine, 10002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lafayette, Louisiana, United States, 70508
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ankara, Turkey, 06280
    Status
    Study Complete
    Location
    GSK Investigational Site
    ALKMAAR, Netherlands, 1815 JD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dabrowa Gornicza, Poland, 41-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Changchun, China, 130012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Springfield, Oregon, United States, 97477
    Status
    Study Complete
    Location
    GSK Investigational Site
    Surakarta, Indonesia, 57126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Feldkirch, Austria, 6800
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78233
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77074
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bonn, Nordrhein-Westfalen, Germany, 53123
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dayton, Ohio, United States, 45459
    Status
    Study Complete
    Location
    GSK Investigational Site
    Balassagyarmat, Hungary, 2660
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nis, Serbia, 18000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trebinje, Bosnia and Herzegovina, 89101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Auburn, Maine, United States, 04210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Anderson, South Carolina, United States, 29621
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63141
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toledo, Ohio, United States, 43614-5809
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 194354
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Miguel de Tucuman, Argentina, 4000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bochum, Nordrhein-Westfalen, Germany, 44787
    Status
    Study Complete
    Location
    GSK Investigational Site
    Reading, United Kingdom, RG2 0TG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33756
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edina, Minnesota, United States, 55435
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grieskirchen, Austria, A-4710
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jersey Shore, Pennsylvania, United States, 17740
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Montclair, California, United States, 91763
    Status
    Study Complete
    Location
    GSK Investigational Site
    Weissenhorn, Bayern, Germany, 89264
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Zaporizhzhia, Ukraine, 69118
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Troy, Michigan, United States, 48098
    Status
    Study Complete
    Location
    GSK Investigational Site
    Manhattan, New York, United States, 10029
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Baotou, China
    Status
    Study Complete
    Location
    GSK Investigational Site
    Karpacz, Poland, 58-540
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ettlingen, Baden-Wuerttemberg, Germany, 76275
    Status
    Study Complete
    Location
    GSK Investigational Site
    Daegu, South Korea, 705-717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55407
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kingwood, Texas, United States, 77339
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shanghai, China, 200003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zadar, Croatia, 23000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bakersfield, California, United States, 93301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Colorado Springs, Colorado, United States, 80910
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barnaul, Russia, 656024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 90-153
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tulsa, Oklahoma, United States, 74127
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rzeszow, Poland, 35-301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bragadiru, Romania, 077025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Davao, Philippines, 8000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salzburg, Austria, A-5020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Łęczyca, Poland, 99-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 4, Czech Republic, 140 46
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mostar, Bosnia and Herzegovina, 88000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Paarl, South Africa, 7646
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gatesville, South Africa, 7764
    Status
    Study Complete
    Location
    GSK Investigational Site
    Langhorne, Pennsylvania, United States, 19047
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Moscow, Russia, 123060
    Status
    Study Complete
    Location
    GSK Investigational Site
    Washington, District of Columbia, United States, 20422
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zabrze, Poland, 41-807
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kutina, Croatia, 44320
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kromeriz, Czech Republic, 767 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Woodbury, Minnesota, United States, 55125
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jinan, Shandong, China, 250033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chelmza, Poland, 87-140
    Status
    Study Complete
    Location
    GSK Investigational Site
    beijing, China, 100070
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zapopan, Jalisco, Mexico, 45040
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sant Boi de Llobregat, Spain, 08830
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bell Vernon, Pennsylvania, United States, 15012
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mission Hills, California, United States, 91345
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jujuy, Argentina, 4600
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Jordan, Utah, United States, 84088
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Florida, United States, 33709
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bensalem, Pennsylvania, United States, 19020
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kosice, Slovakia, 040 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wardenburg, Niedersachsen, Germany, 26203
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenville, North Carolina, United States, 27858
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Guangzhou, Guangdong, China, 510080
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melbourne, Victoria, Australia, 3004
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 195257
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia
    Status
    Study Complete
    Location
    GSK Investigational Site
    Madrid, Spain, 28040
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    East Providence, Rhode Island, United States, 02914
    Status
    Study Complete
    Location
    GSK Investigational Site
    Korsten, South Africa, 6014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbia, South Carolina, United States, 29201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mae Rim, Chiang Mai, Thailand, 50180
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mexico D.F, Mexico, 6700
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Paul, Minnesota, United States, 55130
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muang, Thailand, 11000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tyler, Texas, United States, 75708
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kemerovo, Russia, 650000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burlington, Ontario, Canada, L7N 3V2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greer, South Carolina, United States, 29651
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lancaster, California, United States, 93534
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haifa, Israel, 31096
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cordoba, Argentina, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hefei, China, 230001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Smolensk, Russia, 214 019
    Status
    Study Complete
    Location
    GSK Investigational Site
    St-Petersburg, Russia, 193312
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elizabeth, New Jersey, United States, 07202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenfield, Indiana, United States, 46140
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spittal/Drau, Austria, 9800
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ilawa, Poland, 14-200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Indian Land, South Carolina, United States, 29707
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dasmariñas, Cavite, Philippines, 4114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hawesville, Kentucky, United States, 42348
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trnava, Slovakia, 917 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orenburg, Russia, 460000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ekaterinburg, Russia, 620109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pleven, Bulgaria, 5800
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Thalheim bei Wels, Austria, 4600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Madrid, Spain, 28046
    Status
    Study Complete
    Location
    GSK Investigational Site
    Harsewinkel, Nordrhein-Westfalen, Germany, 33428
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ryazan, Russia, 390005
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deva, Romania, 330084
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dundee, KwaZulu- Natal, South Africa, 3000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nasik, India, 422005
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35216
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Barranquilla, Colombia
    Status
    Study Complete
    Location
    GSK Investigational Site
    Uzhhorod, Ukraine, 88009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kfar Saba, Israel, 44281
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wloszczowa, Poland, 29-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saratov, Russia, 410012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bedford, Bedfordshire, United Kingdom, MK404AW
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hue, Vietnam, 53000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ulyanovsk, Russia, 432063
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 111539
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 91-849
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Shanghai, China, 200040
    Status
    Study Complete
    Location
    GSK Investigational Site
    Izhevsk, Russia, 426063
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marilao, Bulacan, Philippines, 3019
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bacau, Romania, 600252
    Status
    Study Complete
    Location
    GSK Investigational Site
    Istanbul, Turkey, 61080
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pécs, Hungary, 7635
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greensboro, North Carolina, United States, 27405
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham,, Alabama, United States, 35242
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10028
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23220
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ostrava - Belsky les, Czech Republic, 700 30
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sepulveda, California, United States, 91343
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lexington, North Carolina, United States, 27295
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    St-Petersburg, Russia, 199106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gomel, Belarus, 246040
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ventura, California, United States, 93003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bloemfontein, South Africa, 9301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Osaka, Japan, 530-0001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plovdiv, Bulgaria, 4002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wilmington, North Carolina, United States, 28401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bedford, Bedfordshire, United Kingdom, MK42 9DJ
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Detroit, Michigan, United States, 48221
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ciudad Autónoma de Buenos Aires, Argentina, C1426ABP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taipei, Taiwan
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frisco, Texas, United States, 75034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33133
    Status
    Study Complete
    Location
    GSK Investigational Site
    cordoba, Argentina, X5003DCE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33186
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morgantown, West Virginia, United States, 28506
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Gradiska, Bosnia and Herzegovina, 78400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mirabel, Québec, Canada, J7J 2K8
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chattanooga, Tennessee, United States, 37404
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plano, Texas, United States, 75075
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ufa, Russia, 450071
    Status
    Study Complete
    Location
    GSK Investigational Site
    Athens, Greece, 11527
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alexandria, Virginia, United States, 22304
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 115682
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salisbury, North Carolina, United States, 28144
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wonju-si, Kanwon-do, South Korea, 220-701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lampung Selatan, Indonesia, 35373
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Longview, Texas, United States, 75605
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bijeljina, Bosnia and Herzegovina, 76300
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Yaroslavl, Russia, 150062
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beijing, China, 100050
    Status
    Study Complete
    Location
    GSK Investigational Site
    Traverse City, Michigan, United States, 49684
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hyderabad, India, 500038
    Status
    Study Complete
    Location
    GSK Investigational Site
    Phoenix, Arizona, United States, 85018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cakovec, Croatia, 40000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77099
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hialeah, Florida, United States, 33013
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kangwon, South Korea, 200-722
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chorzow, Poland, 41-500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 196084
    Status
    Study Complete
    Location
    GSK Investigational Site
    Paris Cedex 04, France, 75181
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kralovsky Chlmec, Slovakia, 077 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jakarta, Indonesia, 13630
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trisshur, India, 680 002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leipzg, Sachsen, Germany, 04109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winter Park, Florida, United States, 32789
    Status
    Study Complete
    Location
    GSK Investigational Site
    Illescas-Toledo, Spain, 45200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68134
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kralupy nad Vltavou, Czech Republic, 278 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Makassar, Indonesia, 90245
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Saint-Petersburg, Russia, 198328
    Status
    Study Complete
    Location
    GSK Investigational Site
    Buckley, Michigan, United States, 49620
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99204
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gdansk, Poland, 80-405
    Status
    Study Complete
    Location
    GSK Investigational Site
    Iloilo, Philippines, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Buckshaw Village, Chorley, Lancashire, United Kingdom, PR7 7NA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Florence, South Carolina, United States, 29501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novi Marof, Croatia, 42220
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rudna, Czech Republic, 252 19
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cairns, Queensland, Australia, 4870
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lawrenceville, Georgia, United States, 30046
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kuching, Malaysia, 93586
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brcko, Bosnia and Herzegovina, 76000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ploiesti, Romania, 100184
    Status
    Study Complete
    Location
    GSK Investigational Site
    Erie, Pennsylvania, United States, 16508
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33175
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bratislava, Slovakia, 841 04
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barcelona, Spain, 08025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barnaul, Russia, 656038
    Status
    Study Complete
    Location
    GSK Investigational Site
    Doylestown, Pennsylvania, United States, 18901
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zatec, Czech Republic, 438 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Changhua, Taiwan, 500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Louisville, Kentucky, United States, 40202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Innsbruck, Austria, A-6020
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chernivtsi, Ukraine, 58022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zerbst, Sachsen-Anhalt, Germany, 39261
    Status
    Study Complete
    Location
    GSK Investigational Site
    Slupsk, Poland, 76-200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Potchefstroom, South Africa, 2531
    Status
    Study Complete
    Location
    GSK Investigational Site
    Batumi, Georgia, 6000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toledo, Ohio, United States, 43617
    Status
    Study Complete
    Location
    GSK Investigational Site
    Choszczno, Poland, 73-200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-637
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wloclawek, Poland, 87-800
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Marino, California, United States, 91108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pordenone, Friuli-Venezia-Giulia, Italy, 33170
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Donetsk, Ukraine, 83114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rousse, Bulgaria, 7000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33142
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jindrichuv Hradec, Czech Republic, 377 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tuscumbia, Alabama, United States, 35674
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Petersburg, Russia, 192177
    Status
    Study Complete
    Location
    GSK Investigational Site
    Victoria, Texas, United States, 77901
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novi Travnik, Bosnia and Herzegovina
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sabadell (Barcelona), Spain, 08208
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stuhr, Niedersachsen, Germany, 28816
    Status
    Study Complete
    Location
    GSK Investigational Site
    Banjarmasin, Indonesia, 70233
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chonju-si, South Korea, 561-712
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Des Moines, Iowa, United States, 50265
    Status
    Study Complete
    Location
    GSK Investigational Site
    Scottsdale, Arizona, United States, 85258
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charleston, South Carolina, United States, 29407
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33755
    Status
    Study Complete
    Location
    GSK Investigational Site
    Downington, Pennsylvania, United States, 19335
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33135
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mataró, Spain, 08303
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lublin, Poland, 20-093
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zabok, Croatia, 49210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Perm, Russia, 614111
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brooklyn, New York, United States, 11215
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clairton, Pennsylvania, United States, 15025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thabazimbi, South Africa, 0380
    Status
    Study Complete
    Location
    GSK Investigational Site
    Voronezh, Russia, 394066
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shelbyville, Tennessee, United States, 37160
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 12687
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5A 4L8
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Plata, Buenos Aires, Argentina, B1900AXI
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haikou, Hainan, China, 570311
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bolton, Ontario, Canada, L7E 4C8
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Nicolas, Buenos Aires, Argentina, B2900IIC
    Status
    Study Complete
    Location
    GSK Investigational Site
    Formosa, Formosa, Argentina, 3600
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77081
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mosonmagyaróvár, Hungary, 9200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kalamazoo, Michigan, United States, 49009
    Status
    Study Complete
    Location
    GSK Investigational Site
    St-Petersburg, Russia, 194017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 115478
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Gatchina, Russia, 188300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Campulung Muscel, Romania, 115100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guangzhou, China, 510080
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gurjaani, Georgia, 1500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Linz, Austria, 4020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rolling Hills Estates, California, United States, 90274
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Denver, Colorado, United States, 80206
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H2W1T8
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 91910
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Taichung, Taiwan, 437
    Status
    Study Complete
    Location
    GSK Investigational Site
    St.Рetersburg, Russia, 198035
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 109263
    Status
    Study Complete
    Location
    GSK Investigational Site
    Andalusia, Alabama, United States, 36420
    Status
    Study Complete
    Location
    GSK Investigational Site
    Troyan, Bulgaria, 5600
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10220
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55417
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bensheim, Hessen, Germany, 64625
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ciudad Autnónoma de Buenos Aires, Buenos Aires, Argentina, C1186ACB
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham, United Kingdom, B9 5SS
    Status
    Study Complete
    Location
    GSK Investigational Site
    Daytona Beach, Florida, United States, 32117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miamisburg, Ohio, United States, 45342
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hokkaido, Japan, 053-8506
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quebec, Québec, Canada, G1G 4A2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grand Blanc, Michigan, United States, 48439
    Status
    Study Complete
    Location
    GSK Investigational Site
    Keelung, Taiwan, 20401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leesburg, Florida, United States, 34748
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toulouse cedex 9, France, 31059
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Usti nad Labem - Klise, Czech Republic, 400 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bogotá, Colombia, 80CO
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Uijeongbu, Gyeonggi-do, South Korea, 480-717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bratislava, Slovakia, 841 08
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78258
    Status
    Study Complete
    Location
    GSK Investigational Site
    Voorspoed, South Africa, 9459
    Status
    Study Complete
    Location
    GSK Investigational Site
    Durban, South Africa, 4071
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rochester, Minnesota, United States, 55905
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nashville, Tennessee, United States, 37215
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santiago, Región Metro De Santiago, Chile, 7500691
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Linden, New Jersey, United States, 07036
    Status
    Study Complete
    Location
    GSK Investigational Site
    Konjic, Bosnia and Herzegovina, 88400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kansas City, Missouri, United States, 64128
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Russia, 191015
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    San Gabriel, California, United States, 91776
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guntur, India, 522001
    Status
    Study Complete
    Location
    GSK Investigational Site
    St.Petersburg, Russia, 197089
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warminster, Pennsylvania, United States, 18974
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stara Zagora, Bulgaria, 6003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucson, Arizona, United States, 85745
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Songkla, Thailand, 90110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Istanbul, Turkey, 34899
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hoechstadt, Bayern, Germany, 91315
    Status
    Study Complete
    Location
    GSK Investigational Site
    Holesov, Czech Republic, 769 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aurora, Illinois, United States, 60504
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ramnicu Valcea, Romania, 240564
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edgewater, Florida, United States, 32132
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Fernando, Pampanga, Philippines, 2000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gainesville, Georgia, United States, 30501
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Plata, Buenos Aires, Argentina, 1900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zwettl, Austria, 3910
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Dresden, Sachsen, Germany, 01307
    Status
    Study Complete
    Location
    GSK Investigational Site
    Srebrenik, Bosnia and Herzegovina, 75350
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sumy, Ukraine, 40022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23249
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torrance, California, United States, 90502
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kassel, Hessen, Germany, 34121
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hartford, Connecticut, United States, 06105
    Status
    Study Complete
    Location
    GSK Investigational Site
    Depok Timur, Indonesia, 16411
    Status
    Study Complete
    Location
    GSK Investigational Site
    Augsburg, Bayern, Germany, 86150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jekabpils, Latvia, LV 5201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rooihuiskraal, South Africa, 158
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, South Africa, 0022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Varanasi, India, 221001
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Praha 17, Czech Republic, 163 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hrasce Turopoljsko, Croatia, 10020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sainte Jerome, Québec, Canada, J7Z 5T3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chihuahua, Chihuahua, Mexico, 31203
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hialeah, Florida, United States, 33012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Landsdale, Pennsylvania, United States, 19446
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gillespie, Illinois, United States, 62033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Austell, Georgia, United States, 30106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mowbray, South Africa, 7700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77077
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Darmstadt, Hessen, Germany, 64287
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newmarket, Ontario, Canada, L3Y 5G8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ciudad Autonoma de Buenos Aires, Argentina, C1425BEN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grand Island, Nebraska, United States, 68803
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quezon, Philippines, 1104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chennai, India, 600034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rostov-on-Don, Russia, 344022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Princeton, New Jersey, United States, 08540
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Moscow, Russia, 127018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rancho Mirage, California, United States, 92270
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hadera, Israel, PO Box 169
    Status
    Study Complete
    Location
    GSK Investigational Site
    Malang, Indonesia, 65100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melbourne, Florida, United States, 32934
    Status
    Study Complete
    Location
    GSK Investigational Site
    Neuwied, Rheinland-Pfalz, Germany, 56564
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tygerberg, South Africa, 7505
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ingelheim, Rheinland-Pfalz, Germany, 55218
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brandon, Florida, United States, 33511
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taipei, Taiwan, 106
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Daejeon, South Korea, 301-721
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630091
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brasov, Romania, 500283
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vinnytsya, Ukraine, 21001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burien, Washington, United States, 98166
    Status
    Study Complete
    Location
    GSK Investigational Site
    Banja Luka, Bosnia and Herzegovina, 78000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rapid City, South Dakota, United States, 57702
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Russia, 197022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stockton, California, United States, 95207
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vero Beach, Florida, United States, 32960
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangalore, India, 560 010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Avon, Indiana, United States, 46123
    Status
    Study Complete
    Location
    GSK Investigational Site
    Henderson, Nevada, United States, 89014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cuernavaca, Morelos, Mexico, 62350
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Geelong, Victoria, Australia, 3220
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hreljin, Croatia, 51226
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chia-Yi, Taiwan, 613
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Jena, Thueringen, Germany, 07740
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tianjin, China, 300121
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bucheon-Si, Gyeonggi-Do, South Korea, 420-021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cherkassy, Ukraine, 18009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Essen, Nordrhein-Westfalen, Germany, 45355
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tesanj, Bosnia and Herzegovina, 74260
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rochester, Michigan, United States, 48307
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntersville, North Carolina, United States, 28078
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630099
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huai'an, China, 223300
    Status
    Study Complete
    Location
    GSK Investigational Site
    México DF, Mexico, 14050
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Russia, 190103
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Lviv, Ukraine, 79015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bury St Edmunds, Suffolk, United Kingdom, IP30 9QU
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Miami Gardens, Florida, United States, 33169
    Status
    Study Complete
    Location
    GSK Investigational Site
    Teslić, Bosnia and Herzegovina, 74270
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Praha 1, Czech Republic, 110 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Freehold, New Jersey, United States, 07728
    Status
    Study Complete
    Location
    GSK Investigational Site
    İstanbul, Turkey, 34098
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 129301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winchester, Virginia, United States, 22601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gyeonggi-do, South Korea, 410-719
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tokyo, Japan, 194-0023
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cuautitlan Izcalli, Estado de México, Mexico, 54769
    Status
    Study Complete
    Location
    GSK Investigational Site
    Potsdam, Brandenburg, Germany, 14478
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orlando, Florida, United States, 32803
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ibaraki, Japan, 319-1113
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kursk, Russia, 305035
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sacramento, California, United States, 95819
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Greensboro, North Carolina, United States, 27403
    Status
    Study Complete
    Location
    GSK Investigational Site
    Monterrey, Nuevo León, Mexico, 64460
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leipzig, Sachsen, Germany, 04275
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benoni, South Africa, 1501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Parana, Entre Ríos, Argentina, E3100BHK
    Status
    Study Complete
    Location
    GSK Investigational Site
    Canet de Mar - Barcelona, Spain, 08360
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sarnia, Ontario, Canada, N7T 4X3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kvemo Kartli, Georgia, 3000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hokkaido, Japan, 060-0033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Butte, Montana, United States, 59701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntington Beach, California, United States, 92647
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sopot, Poland, 81- 717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Northwood, Middlesex, United Kingdom, HA6 2RN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Goerlitz, Sachsen, Germany, 02826
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bexhill-on-Sea, United Kingdom, TN40 1JJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cordoba, Argentina, X5004BAL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Luzhou, China
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Nagpur, India, 440012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Varanasi, India, 221005
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yinchuan, Ningxia, China, 750004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shanghai, China, 200433
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yogyakarta, Indonesia, 55283
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beijing, China, 100144
    Status
    Study Complete
    Location
    GSK Investigational Site
    Easley, South Carolina, United States, 29640
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sombor, Serbia, 25000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cardiff, United Kingdom, CF14 5GJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Draganic, Croatia, 47201
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Daw Park, South Australia, Australia, 5041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olsztyn, Poland, 10-357
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Petersburg, Russia, 194354
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bronx,, New York, United States, 10457
    Status
    Study Complete
    Location
    GSK Investigational Site
    Johnston, Rhode Island, United States, 02919
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92111
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cumming, Georgia, United States, 30041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Danbury, Connecticut, United States, 06810
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19107
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ryazan, Russia, 390026
    Status
    Study Complete
    Location
    GSK Investigational Site
    Duncanville, Texas, United States, 75116
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rhaunen, Rheinland-Pfalz, Germany, 55624
    Status
    Study Complete
    Location
    GSK Investigational Site
    Flagstaff, Arizona, United States, 86001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corrientes, Argentina, W3400AVK
    Status
    Study Complete
    Location
    GSK Investigational Site
    Derby, United Kingdom, DE22 3NE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boise, Idaho, United States, 83642
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bengbu, China, 233000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pazardjik, Bulgaria, 4400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vicente López, Buenos Aires, Argentina, 1602
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aventura, Florida, United States, 33180
    Status
    Study Complete
    Location
    GSK Investigational Site
    Samsun, Turkey, 55139
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pensacola, Florida, United States, 32514
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nashik, India, 422007
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santa Fe, Santa Fe, Argentina, 3000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guadalajara, Jalisco, Mexico, 44500
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10016
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33185
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tremosna, Czech Republic, 330 11
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vitebsk, Belarus, 210037
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edgbaston, Birmingham, United Kingdom, B15 2SQ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33144
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trinity, Florida, United States, 34655
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbia, South Carolina, United States, 29209
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grimsby, Ontario, Canada, L3M 1P3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hyderabad, India, 500004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chesterfield, Derbyshire, United Kingdom, S40 4AA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sacramento, California, United States, 95817
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 13, Czech Republic, 158 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Youngstown, Ohio, United States, 44501
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ostrava - Poruba, Czech Republic, 70868
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morelia, Michoacán, Mexico, C.P. 58249
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guangxi, China, 530021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rijeka, Croatia, 51000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alappuzha, India, 688524
    Status
    Study Complete
    Location
    GSK Investigational Site
    Neratovice, Czech Republic, 277 11
    Status
    Study Complete
    Location
    GSK Investigational Site
    Timisoara, Romania, 300310
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brest, Belarus, 224027
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Yaroslavl, Russia, 150023
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krotoszyn, Poland, 63-700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-530
    Status
    Study Complete
    Location
    GSK Investigational Site
    River Forest, Illinois, United States, 60305
    Status
    Study Complete
    Location
    GSK Investigational Site
    Long Beach, California, United States, 90822
    Status
    Study Complete
    Location
    GSK Investigational Site
    Idaho Falls, Idaho, United States, 83402
    Status
    Study Complete
    Location
    GSK Investigational Site
    L'Hospitalet de Llobregat, Spain, 08907
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19140
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bukittinggi, Indonesia, 26117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68198
    Status
    Study Complete
    Location
    GSK Investigational Site
    Derqui, Pilar, Buenos Aires, Argentina, B1629AHJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pozuelo de Alarcón/Madrid, Spain, 28223
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33174
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corning, New York, United States, 14830
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glasgow, United Kingdom, G20 0SP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Peterborough, Cambridgeshire, United Kingdom, PE8 6PL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krasnoyarsk, Russia, 660022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Papenburg, Niedersachsen, Germany, 26871
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deggingen, Baden-Wuerttemberg, Germany, 73326
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bridgeport, West Virginia, United States, 26330
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tampa/Florida, Florida, United States, 33607
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fountain Valley, California, United States, 92708
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warszawa, Poland, 01-157
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75254
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Pismo Beach, California, United States, 93449
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shanghai, China, 200072
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbus, Ohio, United States, 43235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pringsewu, Indonesia, 35373
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45231
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 121374
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orlando, Florida, United States, 32811
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33125
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kodaira, Japan, 187-0002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fuerth, Bayern, Germany, 90762
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Yaroslavl, Russia, 150010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cadillac, Michigan, United States, 49601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wroclaw, Poland, 53-439
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ryazan, Russia, 390039
    Status
    Study Complete
    Location
    GSK Investigational Site
    Strasbourg Cedex, France, 67091
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Zenica, Bosnia and Herzegovina, 72000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dueren, Nordrhein-Westfalen, Germany, 52349
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Torrelavega, Spain, 39300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chongqing, China, 400038
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tomsk, Russia, 634012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bucarest, Romania, 050159
    Status
    Study Complete
    Location
    GSK Investigational Site
    Katowice, Poland, 40-040
    Status
    Study Complete
    Location
    GSK Investigational Site
    Panorama, South Africa, 7500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10969
    Status
    Study Complete
    Location
    GSK Investigational Site
    Petrich, Bulgaria, 2850
    Status
    Study Complete
    Location
    GSK Investigational Site
    Johor Bahru, Malaysia, 80100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guadalajara, Mexico, 44670
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guangzhou, Guangdong, China, 510515
    Status
    Study Complete
    Location
    GSK Investigational Site
    Debrecen, Hungary, 4026
    Status
    Study Complete
    Location
    GSK Investigational Site
    Temuco, Región De La Araucania, Chile, 4800798
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ruda Slaska, Poland, 41-709
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630087
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630075
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chicago, Illinois, United States, 60612
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hayden Lake, Idaho, United States, 83835
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ivanovo, Russia, 153462
    Status
    Study Complete
    Location
    GSK Investigational Site
    Asheville, North Carolina, United States, 28801
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mainz, Rheinland-Pfalz, Germany, 55116
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chodziez, Poland, 64-800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tacoma, Washington, United States, 98405
    Status
    Study Complete
    Location
    GSK Investigational Site
    Essen, Nordrhein-Westfalen, Germany, 45136
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Germany, 13507
    Status
    Study Complete
    Location
    GSK Investigational Site
    Badalona, Spain, 08916
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burke, Virginia, United States, 22015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bihac, Bosnia and Herzegovina, 77000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frankfurt, Baden-Wuerttemberg, Germany, 60596
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jiangyin, China
    Status
    Study Complete
    Location
    GSK Investigational Site
    Reno, Nevada, United States, 89502
    Status
    Study Complete
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Feldbach, Austria, 8330
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Martin, Buenos Aires, Argentina, 1650
    Status
    Study Complete
    Location
    GSK Investigational Site
    Debary, Florida, United States, 32173
    Status
    Study Complete
    Location
    GSK Investigational Site
    Missoula, Montana, United States, 59808
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 123182
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M5T 3A9
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Pekanbaru, Indonesia, 28133
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bowling Green, Kentucky, United States, 42101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pell City, Alabama, United States, 35128
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torun, Poland, 87100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beroun, Czech Republic, 266 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bad Woerrishofen, Bayern, Germany, 86825
    Status
    Study Complete
    Location
    GSK Investigational Site
    North Miami Beach, Florida, United States, 33179
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80335
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tukums, Latvia, LV - 3101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sopron, Hungary, 9400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Johannesburg, South Africa, 1686
    Status
    Study Complete
    Location
    GSK Investigational Site
    Constanta, Romania, 900004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hollywood, Florida, United States, 33021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10789
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Honolulu, Hawaii, United States, 96813
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77029
    Status
    Study Complete
    Location
    GSK Investigational Site
    Temple, Texas, United States, 76508
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chernihiv, Ukraine, 14034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ankara, Turkey, 06510
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Huntsville, Texas, United States, 77340
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shanghai, China, 200032
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Petersburg, Russia, 192283
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sremska Kamenica, Serbia, 21204
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fridley, Minnesota, United States, 55432
    Status
    Study Complete
    Location
    GSK Investigational Site
    Williamston, South Carolina, United States, 29697
    Status
    Study Complete
    Location
    GSK Investigational Site
    Odessa, Ukraine, 65009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Osaka, Japan, 591-8555
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muncie, Indiana, United States, 47304-5547
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rudka, Poland, 05-320
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pergamino, Buenos Aires, Argentina, B2700CPM
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mar del Plata, Argentina, B7600FYK
    Status
    Study Complete
    Location
    GSK Investigational Site
    Garden Grove, California, United States, 92844
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vrable, Slovakia, 952 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barcelona, Spain, 08036
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ahmedabad, India, 380007
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hagerstown, Maryland, United States, 21740
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Vancouver, British Columbia, Canada, V7T 2Z3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mysore, India, 570002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8X 5A6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shijiazhuang, Hebei, China, 050000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morganton, North Carolina, United States, 28655
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hohhot, Hainan, China, 010050
    Status
    Study Complete
    Location
    GSK Investigational Site
    Durban, South Africa, 4001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dimitrovgrad, Bulgaria, 6400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15236
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30342
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bangalore, India, 560034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riga, Latvia, LV1038
    Status
    Study Complete
    Location
    GSK Investigational Site
    Opelousas, Louisiana, United States, 70570
    Status
    Study Complete
    Location
    GSK Investigational Site
    Austin, Texas, United States, 78756
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Szczecin, Poland, 70-111
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5M 2V8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33759
    Status
    Study Complete
    Location
    GSK Investigational Site
    Centennial, Colorado, United States, 80112
    Status
    Study Complete
    Location
    GSK Investigational Site
    Buffalo, New York, United States, 14215-1199
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cheonan, South Korea, 330-721
    Status
    Study Complete
    Location
    GSK Investigational Site
    Athens, Alabama, United States, 35611
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mobile, Alabama, United States, 36608
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cerritos, California, United States, 90703
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baotou, Inner Mongolia, China, 014010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 6, Czech Republic, 169 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elizabeth City, North Carolina, United States, 27909
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yaroslavl, Russia, 150003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Soham, Cambridgeshire, United Kingdom, CB7 5JD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 115516
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Great Neck, New York, United States, 11023
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kumamoto, Japan, 861-1196
    Status
    Study Complete
    Location
    GSK Investigational Site
    Osaka, Japan, 558-8558
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78215
    Status
    Study Complete
    Location
    GSK Investigational Site
    DeLand, Florida, United States, 32720
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shtip, Macedonia, 2000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aguascalientes, Aguascalientes, Mexico, 20127
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Spartanburg, South Carolina, United States, 29303
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tokyo, Japan, 103-0027
    Status
    Study Complete
    Location
    GSK Investigational Site
    Colorado Springs, Colorado, United States, 80907
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chicago, Illinois, United States, 60603
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hangzhou, China, 310014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frisco, Texas, United States, 75035
    Status
    Study Complete
    Location
    GSK Investigational Site
    ZUTPHEN, Netherlands, 7207 AE
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kolin, Czech Republic, 280 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630008
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alupka, Ukraine, 98676
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fleming Island, Florida, United States, 32003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tyler, Texas, United States, 75701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brno, Czech Republic, 612 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bratislava, Slovakia, 821 06
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gaffney, South Carolina, United States, 29340
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sofia, Bulgaria, 1000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barcelona, Spain, 08022
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grodno, Belarus, 230017
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13156
    Status
    Study Complete
    Location
    GSK Investigational Site
    Belle Vernon, Pennsylvania, United States, 15012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kutaisi, Georgia, 1600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamburg, Hamburg, Germany, 22763
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santiago de Compostela, Spain, 15706
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gostivar, Macedonia, 1230
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sungai Petani, Kedah, Malaysia, 08000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Foothill Ranch, California, United States, 92610
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Florida, United States, 33704
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lucknow, India, 226018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Skokie, Illinois, United States, 60076
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 12165
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bahia Blanca, Buenos Aires, Argentina, B8000FTD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, Gauteng, South Africa, 0084
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thaba Tshwane, Gauteng, South Africa, 0143
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vidin, Bulgaria, 3700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tampa, Florida, United States, 33603
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oita, Japan, 876-0047
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glendale, Arizona, United States, 85306
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntington Park, California, United States, 90255
    Status
    Study Complete
    Location
    GSK Investigational Site
    LinKou, Taiwan, 333
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dortmund, Nordrhein-Westfalen, Germany, 44263
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kaliningrad, Russia, 236016
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90048
    Status
    Study Complete
    Location
    GSK Investigational Site
    HELMOND, Netherlands, 5707 HA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Izabelin, Poland, 05-080
    Status
    Study Complete
    Location
    GSK Investigational Site
    Voronezh, Russia, 394018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jaipur, India, 302022
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Aschaffenburg, Bayern, Germany, 63739
    Status
    Study Complete
    Location
    GSK Investigational Site
    Detroit, Michigan, United States, 48235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orleans, Ontario, Canada, K4A 5E6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 119049
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leipzig, Sachsen, Germany, 04157
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guangzhou, Guangdong, China, 510120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albany, New York, United States, 12208
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dzialdowo, Poland, 13-200
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Beer-Sheba, Israel, 84101
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Lincoln, Nebraska, United States, 68512
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edison, New Jersey, United States, 8820
    Status
    Study Complete
    Location
    GSK Investigational Site
    Waterloo, Liverpool, Merseyside, United Kingdom, L22 0LG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Westfield, New York, United States, 14787
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kielce, Poland, 25-030
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valjevo, Serbia, 14000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marion, Ohio, United States, 43302
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23219
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jelenia Gora, Poland, 58-506
    Status
    Study Complete
    Location
    GSK Investigational Site
    Daugavpils, Latvia, LA-5403
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lublin, Poland, 20-718
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Irving, Texas, United States, 75039
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bend, Oregon, United States, 97701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodi, New Jersey, United States, 07644
    Status
    Study Complete
    Location
    GSK Investigational Site
    Senj, Croatia, 53270
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 117292
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13125
    Status
    Study Complete
    Location
    GSK Investigational Site
    Manchester, United Kingdom, M15 6SX
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Blue Ridge, Georgia, United States, 30513
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oxon Hill, Maryland, United States, 20745
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63143
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pretoria, Gauteng, South Africa, 0183
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ashkelon, Israel, 78306
    Status
    Study Complete
    Location
    GSK Investigational Site
    Diest, Belgium, 3290
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Can Tho, Vietnam, 90000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pskov, Russia, 180016
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hagen, Nordrhein-Westfalen, Germany, 58095
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lincoln, Nebraska, United States, 68516
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taichung, Taiwan, 404
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jerez de la Frontera, Spain, 11407
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bruchsal, Baden-Wuerttemberg, Germany, 76646
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ternopil, Ukraine, 46002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-567
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seongnam, South Korea, 463-712
    Status
    Study Complete
    Location
    GSK Investigational Site
    Havlickuv brod, Czech Republic, 580 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cali, Colombia, 571
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hlucin, Czech Republic, 748 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Selangor, Malaysia, 68100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Strakonice, Czech Republic, 386 29
    Status
    Study Complete
    Location
    GSK Investigational Site
    Liverpool, Merseyside, United Kingdom, L9 7AL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gainesville, Florida, United States, 32608
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tainan, Taiwan, 704
    Status
    Study Complete
    Location
    GSK Investigational Site
    Altamonte Springs, Florida, United States, 32714
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangalore, India, 560076
    Status
    Study Complete
    Location
    GSK Investigational Site
    Piaseczno, Poland, 05-500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Split, Croatia, 21000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kielce, Poland, 25-365
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77079
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beijing, China, 100029
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lutsk, Ukraine, 43024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tulsa, Oklahoma, United States, 74136
    Status
    Study Complete
    Location
    GSK Investigational Site
    Varazdin, Croatia, 42000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Smithfield, North Carolina, United States, 27577
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Harleysville, Pennsylvania, United States, 19438
    Status
    Study Complete
    Location
    GSK Investigational Site
    Afula, Israel, 18101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elwood, Indiana, United States, 46036
    Status
    Study Complete
    Location
    GSK Investigational Site
    Galdakano, Spain, 48960
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Seattle, Washington, United States, 98104
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Taiyuan, Shanxi, China, 030001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Evansville, Indiana, United States, 47714
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99208
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kozlodui, Bulgaria, 3320
    Status
    Study Complete
    Location
    GSK Investigational Site
    Suceava, Romania, 720284
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nakhon Ratchasima, Thailand, 30000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vilshofen, Bayern, Germany, 94474
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zabrze, Poland, 41-800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bursa, Turkey, 16059
    Status
    Study Complete
    Location
    GSK Investigational Site
    Szikszó, Hungary, H-3800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chiangmai, Thailand, 50200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Busan, South Korea, 602-715
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hannover, Niedersachsen, Germany, 30159
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sukosan, Croatia, 23206
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 107392
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55402
    Status
    Study Complete
    Location
    GSK Investigational Site
    Syracuse, New York, United States, 13210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Svitavy, Czech Republic, 568 25
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olivos, Buenos Aires, Argentina, B1605DSX
    Status
    Study Complete
    Location
    GSK Investigational Site
    Massapequa, New York, United States, 11758
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Smolensk, Russia, 214006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greensboro, North Carolina, United States, 27408
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bydgoszcz, Poland, 85-681
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stara Zagora, Bulgaria, 6000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kirov, Russia, 610027
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bielsko-Biala, Poland, 43-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Veles, Macedonia, 1400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Denpasar, Indonesia, 80114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gdansk, Poland, 80-433
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riga, Latvia, LV1001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valparaiso, Indiana, United States, 46383
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edinburgh, United Kingdom, EH16 4SA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boynton Beach, Florida, United States, 33472
    Status
    Study Complete
    Location
    GSK Investigational Site
    Iowa City, Iowa, United States, 52242
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lansdale, Pennsylvania, United States, 19446
    Status
    Study Complete
    Location
    GSK Investigational Site
    Perm, Russia, 614070
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Banjaluka, Bosnia and Herzegovina, 78000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brick, New Jersey, United States, 08723
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tczew, Poland, 83-110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Knightdale, North Carolina, United States, 27545
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bellingham, Washington, United States, 98225
    Status
    Study Complete
    Location
    GSK Investigational Site
    Augsburg, Bayern, Germany, 86156
    Status
    Study Complete
    Location
    GSK Investigational Site
    Szombathely, Hungary, 9700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kamloops, British Columbia, Canada, V2C 1K7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dakota Dunes, South Dakota, United States, 57049
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yung Kang City, Taiwan, 71044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kielce, Poland, 25-734
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gelsenkirchen, Nordrhein-Westfalen, Germany, 45879
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mendoza, Mendoza, Argentina, 5500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Blagoevgrad, Bulgaria, 2700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wellington, Florida, United States, 33414
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orlando, Florida, United States, 32825
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saratov, Russia, 410018
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bienkowka, Poland, 34-212
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benoni, Gauteng, South Africa, 1501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Istanbul, Turkey, 34020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marietta, Georgia, United States, 30060
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vijayawada, India, 520002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shanghai, China, 200025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rosario, Argentina, 2000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99207
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Coon Rapids, Minnesota, United States, 55433
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hollywood, Maryland, United States, 20636
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pembroke Pines, Florida, United States, 33027
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ocala, Florida, United States, 34471
    Status
    Study Complete
    Location
    GSK Investigational Site
    Konya, Turkey, 42080
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kryvyi Rig, Ukraine, 50096
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Balvi, Latvia, LV - 4501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mobile, Alabama, United States, 36604
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Praha 3, Czech Republic, 130 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Landsberg, Bayern, Germany, 86899
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ventspils, Latvia, LV3601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poznan, Poland, 60-823
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ruedersdorf, Brandenburg, Germany, 15562
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Germany, 12627
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orem, Utah, United States, 84058
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mykolaiv, Ukraine, 54003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Koeln, Nordrhein-Westfalen, Germany, 51069
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warszawa, Poland, 01-192
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brooklyn, New York, United States, 11229
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vic (Barcelona), Spain, 08500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Klenovnik, Croatia, 42244
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hazard, Kentucky, United States, 41701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Goettingen, Niedersachsen, Germany, 37081
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    North Chicago, Illinois, United States, 60064
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charlotte, North Carolina, United States, 28210
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Spisska Nova Ves, Slovakia, 052 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wroclaw, Poland, 50-044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Istanbul, Turkey, 34844
    Status
    Study Complete
    Location
    GSK Investigational Site
    Budapest, Hungary, 1134
    Status
    Study Complete
    Location
    GSK Investigational Site
    Novosibirsk, Russia, 630051
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kyoto, Japan, 607-8062
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tomsk, Russia, 634063
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Czestochowa, Poland, 42-200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tarbes, France, 65013
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bedford Park, South Australia, Australia, 5042
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guri-si, South Korea, 471-701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fayetteville, Tennessee, United States, 37334
    Status
    Study Complete
    Location
    GSK Investigational Site
    Topeka, Kansas, United States, 66606
    Status
    Study Complete
    Location
    GSK Investigational Site
    Concepcion del Uruguay, Entre Ríos, Argentina, 3260
    Status
    Study Complete
    Location
    GSK Investigational Site
    Perm, Russia, 614097
    Status
    Study Complete
    Location
    GSK Investigational Site
    Simferopol, Ukraine, 95043
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wuhan, Hubei, China, 430060
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kragujevac, Serbia, 34000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Presov, Slovakia, 080 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Footscray, Victoria, Australia, 3011
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morningside, Gauteng, South Africa, 2057
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muang Phitsanulok, Thailand, 53000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tel Aviv, Israel, 64239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beaver, Pennsylvania, United States, 15009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 12203
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sisak, Croatia, 44000
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Florencio Varela, Buenos Aires, Argentina, 1888
    Status
    Study Complete
    Location
    GSK Investigational Site
    Scranton, Pennsylvania, United States, 18501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fayetteville, Arkansas, United States, 72703
    Status
    Study Complete
    Location
    GSK Investigational Site
    Magdeburg, Sachsen-Anhalt, Germany, 39104
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hyderabad, India, 500035
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Florida, United States, 33707
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Leipzig, Sachsen, Germany, 04103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sierra Vista, Arizona, United States, 85635
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mar del Plata, Buenos Aires, Argentina, B7600FZN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89119
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mendoza, Mendoza, Argentina, M5500CCG
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N5Y 5K7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Swidnik, Poland, 21-040
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cape Town, South Africa, 7572
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tyne and Wear, United Kingdom, NE29 8NH
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hidalgo, Hidalgo, Mexico, 42070
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 119048
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenville, South Carolina, United States, 29615
    Status
    Study Complete
    Location
    GSK Investigational Site
    Norfolk, Virginia, United States, 23507
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sarajevo, Bosnia and Herzegovina, 71320
    Status
    Study Complete
    Location
    GSK Investigational Site
    Monroeville, Pennsylvania, United States, 15146
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chardon, Ohio, United States, 44024
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Prilep, Macedonia, 7500
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Angelo, Texas, United States, 76904
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lutherville, Maryland, United States, 21093
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kocaeli, Turkey, 41380
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jonesboro, Arkansas, United States, 72401
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19142
    Status
    Study Complete
    Location
    GSK Investigational Site
    Karlsruhe, Baden-Wuerttemberg, Germany, 76227
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Gold River, California, United States, 95670
    Status
    Study Complete
    Location
    GSK Investigational Site
    Killeen, Texas, United States, 76543
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krapina, Croatia, 49000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poznan, Poland, 60-214
    Status
    Study Complete
    Location
    GSK Investigational Site
    Medan, Indonesia, 20154
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90095
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ekaterinburg, Russia, 620149
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sevlievo, Bulgaria, 5400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albuquerque, New Mexico, United States, 87108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chelyabinsk, Russia, 454047
    Status
    Study Complete
    Location
    GSK Investigational Site
    Florencio Varela, Argentina, C1073ABA
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Edinburg, Texas, United States, 78539
    Status
    Study Complete
    Location
    GSK Investigational Site
    Owensboro, Kentucky, United States, 42303-3163
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pale, Bosnia and Herzegovina, 71420
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bronx, New York, United States, 10461
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santa Monica, California, United States, 90404
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mission Viejo, California, United States, 92691
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kaohsiung Hsien, Taiwan, 833
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melnik, Czech Republic, 276 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21224
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aichi, Japan, 457-8510
    Status
    Study Complete
    Location
    GSK Investigational Site
    Solingen, Nordrhein-Westfalen, Germany, 42651
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Nanjing, China, 210009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Police, Poland, 72-010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 90-430
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90036
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ede Gld, Netherlands, 6717RP
    Status
    Study Complete
    Location
    GSK Investigational Site
    ALMELO, Netherlands, 7609 PP
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Pasig, Philippines, 1605
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kaposvár, Hungary, 7400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Summerfield, Florida, United States, 34491
    Status
    Study Complete
    Location
    GSK Investigational Site
    Crestview Hills, Kentucky, United States, 41017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zaporizhzhya, Ukraine, 69001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vsevolzhsk, Russia, 188640
    Status
    Study Complete
    Location
    GSK Investigational Site
    New Port Richey, Florida, United States, 34652
    Status
    Study Complete
    Location
    GSK Investigational Site
    High Point, North Carolina, United States, 27262
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oklahoma City, Oklahoma, United States, 73103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Phoenixville, Pennsylvania, United States, 19460
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kuala Lumpur, Malaysia, 50590
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glen Osmond, Australia, 5064
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gdynia, Poland, 81-384
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saratov, Russia, 410039
    Status
    Study Complete
    Location
    GSK Investigational Site
    Libiaz, Poland, 32-590
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13086
    Status
    Study Complete
    Location
    GSK Investigational Site
    Statesville, North Carolina, United States, 28625
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fuzhou, China, 350025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Quilmes, Buenos Aires, Argentina, B1878FNR
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kansas City, Missouri, United States, 64106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zaporizhia, Ukraine, 69035
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muscle Shoals, Alabama, United States, 35662
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Liepaja, Latvia, LV 3414
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hyogo, Japan, 650-0047
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44122
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 12043
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbus, Georgia, United States, 31904
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beijing, China, 100020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ksawerow, Poland, 95-054
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lovech, Bulgaria, 5500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Foehren, Rheinland-Pfalz, Germany, 54343
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nanchang, China, 330006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 90-302
    Status
    Study Complete
    Location
    GSK Investigational Site
    Osijek, Croatia, 31000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Murrells Inlet, South Carolina, United States, 29576
    Status
    Study Complete
    Location
    GSK Investigational Site
    Viña del Mar, Valparaíso, Chile, 2340000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charleston, South Carolina, United States, 29406-7108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Royal Oak, Michigan, United States, 48073-6769
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palm Harbor, Florida, United States, 34684
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lexington, Kentucky, United States, 40504
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jurmala, Latvia, LV-2010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sestroretsk, Russia, 197706
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melrose Park, Illinois, United States, 60160
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75246
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ankara, Turkey, 6030
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jaipur, India, 302006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tel Hashomer, Israel, 52621
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fall River, Massachusetts, United States, 02720
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-913
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grudziadz, Poland, 86-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rehovot, Israel, 76100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arkhangelsk, Russia, 163061
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kaohsiung, Taiwan, 807
    Status
    Study Complete
    Location
    GSK Investigational Site
    Canton, Georgia, United States, 30114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Crystal River, Florida, United States, 34429
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shenyang, Liaoning, China, 110004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yalta, Ukraine, 98603
    Status
    Study Complete
    Location
    GSK Investigational Site
    Talsi, Latvia, LV - 3201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greensboro, North Carolina, United States, 27401
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Boynton Beach, Florida, United States, 33435
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fu Zhou, China
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sagunto/Valencia, Spain, 46520
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kuala Pilah, Malaysia, 72000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chelmsford, United Kingdom, CM1 7ET
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newton, Kansas, United States, 67114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sturovo, Slovakia, 943 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sacramento, California, United States, 95816
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Vero Beach, Florida, United States, 32958
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bratislava, Slovakia, 851 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Phoenix, Arizona, United States, 85032
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hagen, Nordrhein-Westfalen, Germany, 58089
    Status
    Study Complete
    Location
    GSK Investigational Site
    Visegrad, Bosnia and Herzegovina, 73240
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Franklin, Tennessee, United States, 27064
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tamarac, Florida, United States, 33319
    Status
    Study Complete
    Location
    GSK Investigational Site
    Debrecen, Hungary, 4031
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Detriot, Michigan, United States, 48201
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    West Allis, Wisconsin, United States, 53227
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Waco, Texas, United States, 76710
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Luis, Argentina, 5700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rosario, Argentina, S2000CXP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palo Alto, California, United States, 94304
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ahmedabad, India, 380052
    Status
    Study Complete
    Location
    GSK Investigational Site
    Georgetown, Texas, United States, 78626
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35233
    Status
    Study Complete
    Location
    GSK Investigational Site
    Port Charlotte, Florida, United States, 33952
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santa Coloma de Gramenet, Spain, 08921
    Status
    Study Complete
    Location
    GSK Investigational Site
    Inowroclaw, Poland, 88-100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kutno, Poland, 99-300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Redcliffe, Queensland, Australia, 4020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Komló, Hungary, 7300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Retkovci, Croatia, 32282
    Status
    Study Complete
    Location
    GSK Investigational Site
    Godoy Cruz, Mendoza, Argentina, 5501
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bangalore, India, 560 054
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77062
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oxnard, California, United States, 93030-5841
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cumberland, Rhode Island, United States, 02864
    Status
    Study Complete
    Location
    GSK Investigational Site
    Penticton, British Columbia, Canada, V2A 5C8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jakarta, Indonesia, 13230
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bogota, Colombia, 111211
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krakow, Poland, 31-455
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moravsky Krumlov, Czech Republic, 672 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Van Nuys, California, United States, 91405
    Status
    Study Complete
    Location
    GSK Investigational Site
    Istocno Sarajevo, Bosnia and Herzegovina, 71123
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wroclaw, Poland, 53-301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plymouth, Minnesota, United States, 55441
    Status
    Study Complete
    Location
    GSK Investigational Site
    Verona, New Jersey, United States, 07044
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbus, Ohio, United States, 43215
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sibu, Malaysia, 96000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucson, Arizona, United States, 85710
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Gorzow Wielkopolski, Poland, 66-400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jerusalem, Israel, 91120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Schleswig, Schleswig-Holstein, Germany, 24837
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wooster, Ohio, United States, 44691
    Status
    Study Complete
    Location
    GSK Investigational Site
    Woodstock, Georgia, United States, 30189
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moscow, Russia, 115093
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamburg, Hamburg, Germany, 22291
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32216
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toledo, Ohio, United States, 43606
    Status
    Study Complete
    Location
    GSK Investigational Site
    San luis Potosí, San Luis Potosí, Mexico, 78090
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Novy Jicin, Czech Republic, 741 01
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valmiera, Latvia, LV-4201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tokyo, Japan, 103-0028
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lodz, Poland, 90-203
    Status
    Study Complete
    Location
    GSK Investigational Site
    Khon Kaen, Thailand, 40002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gauting, Bayern, Germany, 82131
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chongqing, China, 400016
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sympheropol, Ukraine, 95017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lublin, Poland, 20-552
    Status
    Study Complete
    Location
    GSK Investigational Site
    Virginia Beach, Virginia, United States, 23454
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Covina, California, United States, 91790
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Miguel de Tucumán, Argentina, 4000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bielsko-Biala, Poland, 43-316
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cordoba, Argentina, 5900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Erpent, Belgium, 5101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seoul, South Korea, 130-872
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jaro, Iloilo City, Philippines, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hermosillo, Sonora, Mexico, 83000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Port Orange, Florida, United States, 32129
    Status
    Study Complete
    Location
    GSK Investigational Site
    Maitland, Florida, United States, 32751
    Status
    Terminated/Withdrawn

    Study documents

    Clinical study report
    Available language(s): English
    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Results posted on ClinicalTrials.gov

    Recruitment status
    Study complete
    Actual primary completion date
    2015-15-07
    Actual study completion date
    2015-15-07

    Plain language summaries

    Summary of results in plain language
    Available language(s): English

    To view plain language summaries on trialsummaries.com click here.

    Additional information about the trial

    Participate in clinical trial
    Additional information
    Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
    Click here
    Access to clinical trial data by researchers
    Visit website